Related Experiment Videos
Nomenclature of central and peripheral dopaminergic sites and receptors
Biochemical Pharmacology
|August 15, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Demyelinating Charcot-Marie-Tooth neuropathy associated with FBLN5 mutations.
European journal of neurology·2020
Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2.
Clinical genetics·2018
Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose.
Translational psychiatry·2016
Recent advances in Tumor microenvironment-responsive pro-antibody to overcome on-target, off-Tumor toxicity.
Biochemical pharmacology·2026
Aldosterone synthase inhibitors may alter how primary care treats hypertension.
American journal of hypertension·2026
The hypertension specialist's perspective: aldosterone synthase inhibitors to fill the gap in difficult-to-control and resistant hypertension.
American journal of hypertension·2026
From bench to formulary: a pharmacological appraisal of aldosterone synthase inhibitors for uncontrolled and resistant hypertension.
American journal of hypertension·2026
Lessons from the history of antipsychotic discovery: part 3 - muscarinic mechanisms.
BJPsych bulletin·2026
Topical and oral chemical pretreatments for photodynamic therapy in actinic keratoses: A scoping review.
Journal of photochemistry and photobiology. B, Biology·2026